Delivery Order SPE2DB24D1205-SPE2DB25FCZWE
- Not listed
- The Defense Logistics Agency awarded a $5,501.30 delivery order to AmerisourceBergen Drug Corp for Provocholine inhalation solution in 18ML packs, with an ultimate completion date of August 25, 2025. This competitively awarded, firm fixed-price contract represents a non-set-aside procurement and is being performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The order is a child delivery order issued under AmerisourceBergen's larger indefinite delivery contract with...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Provocholine inhalation solution in an 18mL pack configuration, valued at $1,100.26 under a firm fixed-price contract type. The award was made on August 25, 2025, with an ultimate completion date of August 26, 2025. This non-competitive delivery order represents a purchase of pharmaceutical products to support federal medical supply requirements. AmerisourceBergen Drug Corp, headquartered in Conshohocken,...
- The Defense Logistics Agency awarded a $2,750.65 delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Provocholine Inhalation Solution in 18 mL packs. This is a firm fixed-price contract with a completion date of August 26, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation, reflecting AmerisourceBergen's established capability to meet federal...
- The Defense Logistics Agency awarded a $1,655.58 firm fixed price delivery order to AmerisourceBergen Drug Corp for Provocholine inhalation solution in 18ml packaging under contract 4569133382. The award, issued on August 18, 2025, with completion targeted for August 19, 2025, represents a child order under AmerisourceBergen's larger pharmaceutical supply vehicle. The contract is unset-aside and competitively awarded, with performance to occur at the company's corporate office location in...
- The Defense Logistics Agency awarded a $10,515.14 firm fixed price delivery order to AmerisourceBergen Drug Corp for the supply of Provocholine 100 mg vials. This non-set-aside contract was awarded on July 21, 2025, with an ultimate completion date of July 22, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. Provocholine is a pharmaceutical product used in respiratory function testing and is part of the...
- This is a firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution and healthcare solutions provider. The contract, valued at $7,077.65, is for the supply of Provocholine inhalation solution. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which supports the provision of a wide range of pharmaceutical...
- This delivery order, awarded on July 23, 2025, procures Provocholine inhalation solution in 18ML pack quantities for the Defense Department's Medical Supply Chain with a ceiling value of $6,732.76. The award is issued under firm fixed pricing with an ultimate completion date of July 24, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was selected as the awardee through competitive procurement with no set-aside designation. This delivery order is issued as a...
- This federal contract award is a delivery order valued at $4,265.39 issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider based in Conshohocken, Pennsylvania. The contract is for the provision of Provocholine Inhalation Solution, a pharmaceutical product, with a period of performance extending through June 2025. The contract does not have a set-aside designation, indicating it was open to full and open...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $4,401.04, is for the supply of Provocholine Inhalation Solution, a medical product used in the diagnosis of respiratory disorders. The contract has an ultimate completion date of April 29, 2025 and is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of Provocholine 100 mg vials, with a ceiling value of $1,895.08 and a firm fixed price structure. This non-set-aside, competitively awarded contract is scheduled for completion by August 22, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a single transaction under AmerisourceBergen's...
- SPE2DB24D1205Indefinite Delivery Contract
- SPE2DB24D1205-SPE2DB25FCZWEDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,650.39 to AmerisourceBergen Drug Corp for Provocholine inhalation solution in 18ML packs, with an ultimate completion date of August 26, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), which carries a ceiling value of $999.999 billion and runs through December 2026, serving as a comprehensive global pharmaceutical support vehicle for military healthcare programs worldwide. Provocholine is a methacholine chloride bronchial challenge agent used diagnostically to assess airway reactivity and is commonly procured through the DLA supply chain to support medical testing capabilities across Department of Defense facilities and military medical treatment facilities. This delivery order represents a routine pharmaceutical procurement under the established prime vendor relationship, reflecting AmerisourceBergen's ongoing role as a critical supplier of specialty medications, brand-name and generic drugs, and medical supplies to the Defense Health Agency and broader federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.7k | 8/25/25 |